Ide A - Search Results

1

Pretreatment with eplerenone reduces stroke volume in mouse middle cerebral artery occlusion model.

Iwanami J, Mogi M, Okamoto S, Gao XY, Li JM, Min LJ, Ide A, Tsukuda K, Iwai M, Horiuchi M. Iwanami J, et al. Among authors: ide a. Eur J Pharmacol. 2007 Jul 2;566(1-3):153-9. doi: 10.1016/j.ejphar.2007.03.043. Epub 2007 Mar 31. Eur J Pharmacol. 2007. PMID: 17475237

2

Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress.

Hamai M, Iwai M, Ide A, Tomochika H, Tomono Y, Mogi M, Horiuchi M. Hamai M, et al. Among authors: ide a. Neuropharmacology. 2006 Sep;51(4):822-8. doi: 10.1016/j.neuropharm.2006.05.029. Epub 2006 Jul 7. Neuropharmacology. 2006. PMID: 16824557

3

The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage.

Iwai M, Chen R, Ide A, Iwanami J, Tomochika H, Tomono Y, Mogi M, Horiuchi M. Iwai M, et al. Among authors: ide a. J Hypertens. 2006 Oct;24(10):2023-31. doi: 10.1097/01.hjh.0000244952.54738.f6. J Hypertens. 2006. PMID: 16957563

4

Amlodipine treatment reduces stroke size in apolipoprotein E-deficient mice.

Mogi M, Iwai M, Chen R, Iwanami J, Ide A, Tsukuda K, Yoshii T, Horiuchi M. Mogi M, et al. Among authors: ide a. Am J Hypertens. 2006 Nov;19(11):1144-9. doi: 10.1016/j.amjhyper.2006.04.009. Am J Hypertens. 2006. PMID: 17070425

5

Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation.

Iwai M, Liu HW, Chen R, Ide A, Okamoto S, Hata R, Sakanaka M, Shiuchi T, Horiuchi M. Iwai M, et al. Among authors: ide a. Circulation. 2004 Aug 17;110(7):843-8. doi: 10.1161/01.CIR.0000138848.58269.80. Epub 2004 Aug 2. Circulation. 2004. PMID: 15289370

6

Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress.

Tsuda M, Iwai M, Li JM, Li HS, Min LJ, Ide A, Okumura M, Suzuki J, Mogi M, Suzuki H, Horiuchi M. Tsuda M, et al. Among authors: ide a. Hypertension. 2005 Apr;45(4):545-51. doi: 10.1161/01.HYP.0000157409.88971.fc. Epub 2005 Feb 21. Hypertension. 2005. PMID: 15723967

7

Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice.

Suzuki J, Iwai M, Li Z, Li JM, Min LJ, Ide A, Yoshii T, Oshita A, Mogi M, Horiuchi M. Suzuki J, et al. Among authors: ide a. J Hypertens. 2005 Jul;23(7):1383-9. doi: 10.1097/01.hjh.0000173521.91104.5f. J Hypertens. 2005. PMID: 15942461

8

Sex difference in vascular injury and the vasoprotective effect of valsartan are related to differential AT2 receptor expression.

Okumura M, Iwai M, Ide A, Mogi M, Ito M, Horiuchi M. Okumura M, et al. Among authors: ide a. Hypertension. 2005 Sep;46(3):577-83. doi: 10.1161/01.HYP.0000178564.14464.80. Epub 2005 Aug 15. Hypertension. 2005. PMID: 16103268

9

Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.

Iwai M, Chen R, Li Z, Shiuchi T, Suzuki J, Ide A, Tsuda M, Okumura M, Min LJ, Mogi M, Horiuchi M. Iwai M, et al. Among authors: ide a. Circulation. 2005 Sep 13;112(11):1636-43. doi: 10.1161/CIRCULATIONAHA.104.525550. Epub 2005 Sep 6. Circulation. 2005. PMID: 16145000

10

Attenuation of inflammatory vascular remodeling by angiotensin II type 1 receptor-associated protein.

Oshita A, Iwai M, Chen R, Ide A, Okumura M, Fukunaga S, Yoshii T, Mogi M, Higaki J, Horiuchi M. Oshita A, et al. Among authors: ide a. Hypertension. 2006 Oct;48(4):671-6. doi: 10.1161/01.HYP.0000238141.99816.47. Epub 2006 Aug 21. Hypertension. 2006. PMID: 16923992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters